John A. Lewicki, President & CEO at OncoMed Pharmaceuticals Inc (OMED), sold 4,557 shares at $2.68 ($12K) on 2018-04-24, disclosed to the SEC on 2018-04-26.
Open-market sale of $12k OMED by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2017-10-12 | $5K | — | Filing → |